edetic acid has been researched along with Myocardial Infarction in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (19.35) | 18.7374 |
| 1990's | 9 (14.52) | 18.2507 |
| 2000's | 10 (16.13) | 29.6817 |
| 2010's | 21 (33.87) | 24.3611 |
| 2020's | 10 (16.13) | 2.80 |
| Authors | Studies |
|---|---|
| Chae, IH; Han, D; Kang, SH; Yoon, CH; Youn, TJ | 1 |
| Anstrom, KJ; Aude, YW; Boineau, R; Elliott, T; Escolar, E; Farkouh, ME; Fonseca, V; Gosnell, L; Jones, TLZ; Joubert, BR; Kim, H; Lamas, GA; Lewis, EF; Mark, DB; Mon, AC; Nathan, DM; Navas-Acien, A; Newman, JD; Rosenberg, Y; Santella, RM; Stylianou, M | 1 |
| Yen, JS; Yen, TH | 1 |
| Goertz, C; Lamas, GA; Lee, KL; Lewis, EF; Mark, DB; Nahin, RL; Roberts, RS; Stylianou, M; Ujueta, F | 1 |
| Dans, AL; Forster, R; Sulit, DV; Tan, FN; Villarruz-Sulit, MV | 1 |
| Anstrom, KJ; Boineau, R; Escolar, E; Goertz, C; Kim, H; Lamas, GA; Lee, KL; Mark, DB; Nahin, RL; Ujueta, F | 1 |
| Alam, ZH; Arenas, IA; Lamas, GA; Navas-Acien, A; Nigra, AE; Ujueta, F | 1 |
| Flugelman, MY; Schliamser, JE; Shiran, A | 1 |
| Kavsak, PA; Kittanakom, S | 1 |
| Alegría, E; Bautista, J; Bertomeu-Gonzalez, V; Cid-Alvarez, B; Cordero, A; Escribano, D; Fernández-Cisnal, A; Ferreiro, JL; Juskova, M; Trillo, R | 1 |
| Jahangir, A; Mookadam, F; Murarka, S; Sultan, S; Tajik, AJ | 1 |
| Arenas, IA; Ergui, I; Lamas, GA; Navas-Acien, A | 1 |
| Ainsworth, C; Clark, L; Kavsak, PA; Lamers, S; Malinowski, P; Mark, CT; Roy, C; Scott, T | 1 |
| Aude, YW; Diaz, D; Fonseca, V; Lamas, GA | 1 |
| Calderon Moreno, R; Diaz, D; Escolar, E; Fonseca, V; Lamas, GA; Nathan, DM; Navas-Acien, A; Newman, J; Schmedtje, JF | 1 |
| Arenas, IA; Boineau, R; Diaz, D; Escolar, E; Golden, P; Kim, H; Lamas, GA; Lee, KL; Lindblad, L; Mark, DB; Ujueta, F | 1 |
| Boineau, R; Drisko, J; Goertz, C; Lamas, GA; Lee, KL; Lewis, EF; Lindblad, L; Mark, DB; Nahin, RL; Rozema, T | 1 |
| Bauchner, H; Fontanarosa, PB; Golub, RM | 1 |
| Nissen, SE | 1 |
| Bittl, JA | 1 |
| Kleinman, B | 1 |
| Lamas, GA; Lee, KL; Mark, D | 1 |
| Boineau, R; Escolar, E; Goertz, C; Lamas, GA; Lee, KL; Lewis, EF; Lindblad, L; Magaziner, A; Mark, DB; Nahas, R; Nahin, RL; Ouyang, P; Rosenberg, Y; Rozema, T | 1 |
| Kaul, S | 1 |
| Almén, T; Ignarro, LJ; Jynge, P; Karlsson, JO; Lundström, I | 1 |
| Lamas, GA | 1 |
| Issa, OM; Lamas, GA | 1 |
| Beloglazova, IB; Boldyreva, MA; Dergilev, KV; Makarevich, PI; Menshikov, MY; Parfyonova, YV; Tsokolaeva, ZI; Zubkova, ES | 1 |
| Einecke, D | 1 |
| Adriaens, P; Bogaert, J; Bosmans, H; Cresens, E; Dymarkowski, S; Marchal, G; Ni, Y; Verbruggen, A; Zhang, H | 1 |
| Hemmingsson, A | 1 |
| Dan, K; Nakamura, N; Toyota, S | 1 |
| Kubota, F; Osada, T; Ozaki, Y; Satoh, K; Takeda, S; Tsuyuguchi, N; Yatomi, Y | 1 |
| Latger-Cannard, V; Lecompte, T; Lesesve, JF | 1 |
| Chappell, LT | 1 |
| Amundsen, BH; Haraldseth, O; Jynge, P; Larsson, HB; Skjold, A; Støylen, A; Wiseth, R | 1 |
| Godal, HC; Holm, B | 1 |
| Baum, H; Booksteegers, P; Neumeier, D; Steinbeck, G | 1 |
| Balogh, D; Calzolari, C; Larue, C; Mair, J; Mair, P; Puschendorf, B | 1 |
| Gil, F; Hernández, AF; Pla, A; Valenzuela, A; Villanueva, E | 1 |
| Canepa-Anson, R; Collinson, PO; Siu, L; Stubbs, PJ; Thomas, S; Vasudeva, P | 1 |
| Baglin, TP; Byrne, CD; Flynn, PD; Rota, S; Wareham, NJ | 1 |
| Kupersmith, J; Li, ZY; Maldonado, C; Szabo, T; Wead, WB | 1 |
| Arheden, H; Bremerich, J; Higgins, CB; Saeed, M; Wendland, MF | 2 |
| Davies, JE; Downie, PF; Ng, LL; Squire, IB; Talwar, S | 1 |
| Mitchell, JR; Page, RL | 1 |
| Hynie, I; Meuffels, M; Poznanski, WJ | 1 |
| Deegan, T; Efendigil, MC; Harley, A; McKendrick, CS | 1 |
| Askenazi, J; Davis, MA; Holman, BL; Jones, AG; Maroko, PR | 1 |
| Fry, GL; Hoak, JC; Wu, KK | 1 |
| Fenwick, MK; Motwani, JG; Struthers, AD | 1 |
| Davis, WP; Graham, P | 1 |
| Abendschein, DR; Fontanet, HL; Nohara, R | 1 |
| Derugin, N; Finkbeiner, WE; Higgins, CB; Saeed, M; Wagner, S; Wendland, MF | 1 |
| Gries, WJ; Hwang, MH; Murdock, DK; Piao, ZE; Scanlon, PJ | 1 |
| Gornet, TG; Wu, AH | 1 |
| Dintenfass, L; Forbes, CD | 1 |
| Rubenstein, I; Surawicz, B; Weiss, DL | 1 |
| Marriott, HJ | 1 |
8 review(s) available for edetic acid and Myocardial Infarction
| Article | Year |
|---|---|
Chelation therapy for atherosclerotic cardiovascular disease.
Topics: Angina Pectoris; Arteriosclerosis; Cause of Death; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Stroke | 2020 |
Chelation therapy in cardiovascular disease: an update.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Myocardial Infarction; Off-Label Use; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Chelation therapy to prevent diabetes-associated cardiovascular events.
Topics: Atherosclerosis; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Diabetes Mellitus; Diabetic Cardiomyopathies; Edetic Acid; Glycation End Products, Advanced; Humans; Metals; Myocardial Infarction; National Institutes of Health (U.S.); Oxidation-Reduction; Randomized Controlled Trials as Topic; United States | 2018 |
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
Topics: Antioxidants; Arsenic; Ascorbic Acid; Atherosclerosis; Cadmium; Calcium Chelating Agents; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Copper; Diabetes Complications; Diabetes Mellitus; Edetic Acid; Glycation End Products, Advanced; Hospitalization; Humans; Iron; Lead; Lipid Metabolism; Mercury; Myocardial Infarction; Myocardial Revascularization; Oxidative Stress; Randomized Controlled Trials as Topic; Stroke | 2019 |
Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
Topics: Animals; Antineoplastic Agents; Antioxidants; Biological Mimicry; Colorectal Neoplasms; Edetic Acid; Ethylenediamines; Humans; Manganese; Molecular Structure; Myocardial Infarction; Oxidative Stress; Percutaneous Coronary Intervention; Pyridoxal Phosphate; Reactive Oxygen Species; Structure-Activity Relationship; Superoxide Dismutase; Treatment Outcome | 2015 |
Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients.
Topics: Atherosclerosis; Calcium Chelating Agents; Chelation Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Edetic Acid; Heavy Metal Poisoning; Humans; Metals, Heavy; Myocardial Infarction; Poisoning; Risk Factors; Secondary Prevention; Survivors; Treatment Outcome | 2016 |
Should EDTA chelation therapy be used instead of long-term clopidogrel plus aspirin to treat patients at risk from drug-eluting stents?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Chelating Agents; Clopidogrel; Drug Implants; Edetic Acid; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Ticlopidine | 2007 |
Management of cardiac dysrhythmias complicating acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Bradycardia; Bretylium Compounds; Diazepam; Edetic Acid; Electrocardiography; Heart Block; Humans; Hydrocortisone; Isoproterenol; Lidocaine; Metaraminol; Myocardial Infarction; Neostigmine; Norepinephrine; Ouabain; Phenytoin; Potassium Chloride; Procainamide; Propranolol; Quinidine; Tachycardia; Valsalva Maneuver | 1968 |
10 trial(s) available for edetic acid and Myocardial Infarction
| Article | Year |
|---|---|
The trial to assess chelation therapy 2 (TACT2): Rationale and design.
Topics: Chelating Agents; Chelation Therapy; Diabetes Mellitus; Double-Blind Method; Edetic Acid; Humans; Myocardial Infarction; Vitamins | 2022 |
Differential Outcomes With Edetate Disodium-Based Treatment Among Stable Post Anterior vs. Non-Anterior Myocardial Infarction Patients.
Topics: Angina Pectoris; Chelating Agents; Chelation Therapy; Edetic Acid; Humans; Middle Aged; Myocardial Infarction; Treatment Outcome | 2020 |
Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT).
Topics: Aged; Calcium Chelating Agents; Chelation Therapy; Diabetes Complications; Double-Blind Method; Edetic Acid; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2020 |
Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings.
Topics: Chelating Agents; Chelation Therapy; Edetic Acid; Environmental Pollutants; Female; Humans; Male; Metals; Myocardial Infarction | 2020 |
Enhanced vasculotoxic metal excretion in post-myocardial infarction patients following a single edetate disodium-based infusion.
Topics: Aged; Aged, 80 and over; Calcium Chelating Agents; Chelation Therapy; Cross-Sectional Studies; Diet; Edetic Acid; Environmental Pollutants; Florida; Humans; Life Style; Male; Metals; Middle Aged; Myocardial Infarction | 2017 |
The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT).
Topics: Aged; Chelating Agents; Chelation Therapy; Diabetes Mellitus; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Edetic Acid; Female; Humans; Incidence; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Arterial Disease; Placebos; Treatment Outcome | 2019 |
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.
Topics: Aged; Angina Pectoris; Atherosclerosis; Chelating Agents; Double-Blind Method; Edetic Acid; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Recurrence; Risk; Stroke; Treatment Outcome | 2013 |
From the National Heart, Lung, and Blood Institute (NHLBI): EDTA chelation therapy modestly reduces cardiovascular events.
Topics: Ascorbic Acid; Chelating Agents; Chelation Therapy; Edetic Acid; Humans; Myocardial Infarction; National Heart, Lung, and Blood Institute (U.S.); United States; Vitamin B Complex; Vitamins | 2013 |
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).
Topics: Age Factors; Aged; Blood Glucose; Chelating Agents; Diabetes Complications; Double-Blind Method; Edetic Acid; Female; Glycation End Products, Advanced; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Risk Factors; Treatment Outcome | 2014 |
Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunction.
Topics: Captopril; Chromium Radioisotopes; Chronic Disease; Creatinine; Edetic Acid; Glomerular Filtration Rate; Heart Failure; Humans; Inulin; Kidney Function Tests; Myocardial Infarction; Renal Circulation; Single-Blind Method; Ventricular Function, Left | 1992 |
44 other study(ies) available for edetic acid and Myocardial Infarction
| Article | Year |
|---|---|
Attenuation of ischemia-reperfusion injury by intracoronary chelating agent administration.
Topics: Animals; Aorta, Thoracic; Chelating Agents; Disease Models, Animal; Echocardiography; Edetic Acid; Male; Mitochondria; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Salvage Therapy; Stroke Volume; Swine; Ventricular Function, Left; Ventricular Remodeling | 2022 |
Chelation trial in patients with cardiovascular disease.
Topics: Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Clinical Trials as Topic; Edetic Acid; Humans; Myocardial Infarction | 2023 |
Adjuvant Therapy for Acute Myocardial Infarction: Differential Outcomes with Edetate Disodium-Based Treatment Among Stable Post-Anterior vs. Non-Anterior Myocardial Infarction Patients.
Topics: Combined Modality Therapy; Edetic Acid; Humans; Myocardial Infarction | 2020 |
Impact of Switching Sample Types for High-Sensitivity Cardiac Troponin I Assays in the 0/1 Hour Algorithms.
Topics: Algorithms; Biomarkers; Diagnostic Errors; Diagnostic Tests, Routine; Edetic Acid; Heparin; Humans; Myocardial Infarction; Specimen Handling; Troponin I | 2021 |
Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
Topics: Edetic Acid; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Thrombectomy; Treatment Outcome | 2021 |
Macrocomplexes and discordant high-sensitivity cardiac troponin concentrations.
Topics: Aged; Edetic Acid; Female; Humans; Limit of Detection; Male; Middle Aged; Myocardial Infarction; Polyethylene Glycols; Reproducibility of Results; Troponin I | 2018 |
Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny.
Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke | 2013 |
Concerns about reliability in the Trial to Assess Chelation Therapy (TACT).
Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke | 2013 |
Chelation therapy may improve cardiovascular health.
Topics: Canada; Chelation Therapy; Clinical Trials as Topic; Edetic Acid; Humans; Myocardial Infarction; Treatment Outcome; United States | 2013 |
Chelation therapy and cardiovascular outcomes.
Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke | 2013 |
Chelation therapy and cardiovascular outcomes.
Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke | 2013 |
Chelation therapy and cardiovascular outcomes--in reply.
Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke | 2013 |
Are concerns about reliability in the trial to assess chelation therapy fair grounds for a hasty dismissal?: An alternative perspective.
Topics: Chelating Agents; Diabetes Complications; Edetic Acid; Female; Humans; Male; Myocardial Infarction | 2014 |
Cardiology Patient Page. Chelation therapy: a new look at an old treatment for heart disease, particularly in diabetics.
Topics: Chelating Agents; Chelation Therapy; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Edetic Acid; Environmental Pollutants; Humans; Infusions, Intravenous; Metals, Heavy; Multicenter Studies as Topic; Myocardial Infarction | 2015 |
Comparison of cardiac stem cell sheets detached by Versene solution and from thermoresponsive dishes reveals similar properties of constructs.
Topics: Animals; Apoptosis; Cell Culture Techniques; Cell Proliferation; Cell Separation; Cell Survival; Edetic Acid; Gap Junctions; Humans; Myocardial Infarction; Myocardium; Rats; Regenerative Medicine; Stem Cell Transplantation; Stem Cells | 2017 |
[Provacative study results: do infarct patients benefit from chelate therapy?].
Topics: Chelation Therapy; Complementary Therapies; Diabetic Angiopathies; Double-Blind Method; Edetic Acid; Financing, Personal; Free Radicals; Germany; Heavy Metal Poisoning; Humans; Myocardial Infarction; Poisoning; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Exploring multifunctional features of necrosis avid contrast agents.
Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; Mesoporphyrins; Metalloporphyrins; Myocardial Infarction; Necrosis; Organic Chemicals; Pyridoxal Phosphate; Rats; Rhabdomyosarcoma; Swine; Tissue Distribution | 2002 |
[MnDPDP--contrast medium with protective effect in acute myocardial infarction].
Topics: Animals; Cardiotonic Agents; Contrast Media; Edetic Acid; Mice; Mice, Transgenic; Myocardial Infarction; Myocardial Reperfusion Injury; Pyridoxal Phosphate; Swine | 2002 |
Pseudo gray platelet syndrome in a patient with acute myocardial infarction.
Topics: Aged; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Diagnosis, Differential; Edetic Acid; False Positive Reactions; Humans; Male; Myocardial Infarction; Syndrome | 2002 |
Clear visual detection of circulating platelet aggregates in acute myocardial infarction using a flow cytometer equipped with an imaging device.
Topics: Blood Platelets; Diagnostic Imaging; Edetic Acid; Flow Cytometry; Formaldehyde; Humans; Myocardial Infarction; Platelet Aggregation; Polymers | 2004 |
Pseudo-storage pool disease due to platelet degranulation in EDTA-collected peripheral blood: a rare artifact.
Topics: Aged; Blood Platelets; Blood Specimen Collection; Cell Degranulation; Diagnostic Errors; Edetic Acid; Female; Histocytochemistry; Humans; Myocardial Infarction; Platelet Count; Platelet Storage Pool Deficiency | 2005 |
Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.
Topics: Adult; Aged; Biomarkers; Contrast Media; Coronary Vessels; Echocardiography; Edetic Acid; Female; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Pyridoxal Phosphate; Treatment Outcome | 2007 |
Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Protein Electrophoresis; Child; Child, Preschool; Edetic Acid; Female; Fibrin; Fibrinogen; Hip Prosthesis; Humans; Infant; Male; Middle Aged; Molecular Weight; Myocardial Infarction; Postoperative Period; Sex Factors | 1984 |
A rapid assay for the quantification of myoglobin: evaluation and diagnostic relevance in the diagnosis of acute myocardial infarction.
Topics: Citrates; Edetic Acid; Evaluation Studies as Topic; Female; Humans; Male; Myocardial Infarction; Myoglobin; Nephelometry and Turbidimetry; Reference Values | 1994 |
Use of cardiac troponin I to diagnose perioperative myocardial infarction in coronary artery bypass grafting.
Topics: Aged; Coronary Artery Bypass; Edetic Acid; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intraoperative Period; Kinetics; Male; Middle Aged; Myocardial Infarction; Troponin; Troponin I | 1994 |
Characterization of paraoxonase activity in pericardial fluid: usefulness as a marker of coronary disease.
Topics: Aryldialkylphosphatase; Biomarkers; Body Fluids; Coronary Disease; Edetic Acid; Enzyme Activation; Enzyme Stability; Hot Temperature; Humans; Isoelectric Focusing; Kinetics; Myocardial Infarction; Pericardium; Phosphoric Monoester Hydrolases | 1993 |
Rapid troponin T measurement in whole blood for detection of myocardial damage.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Biomarkers; Blood Chemical Analysis; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Female; Heart Diseases; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Sensitivity and Specificity; Troponin; Troponin T | 1995 |
Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Platelets; Blood Specimen Collection; Calcium; Citrates; Cohort Studies; Edetic Acid; Female; Humans; Ionophores; Male; Membrane Lipids; Middle Aged; Models, Biological; Myocardial Infarction; Phospholipids; Platelet Activation; Platelet Aggregation Inhibitors; Reproducibility of Results; Sodium Citrate; Thrombin | 1996 |
Mechanisms of triggered activity induction at the border zone of normal and abnormal cardiac tissue.
Topics: Action Potentials; Animals; Cardiovascular Agents; Edetic Acid; In Vitro Techniques; Microelectrodes; Myocardial Infarction; Perfusion; Purkinje Fibers; Sheep; Terminology as Topic; Time Factors | 1996 |
Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.
Topics: Analysis of Variance; Animals; Contrast Media; Coronary Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Echo-Planar Imaging; Edetic Acid; Female; Follow-Up Studies; Magnetic Resonance Imaging; Manganese; Metabolic Clearance Rate; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 2000 |
Prolonged stability of endogenous cardiotrophin-1 in whole blood.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Angina, Unstable; Aprotinin; Blood Proteins; Blood Specimen Collection; Cytokines; Edetic Acid; Female; Heart Ventricles; Humans; Ice; Immunoassay; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction; Peptide Fragments; Temperature; Time Factors | 2001 |
Thallium-like test for myocardial viability with MnDPDP-enhanced MRI.
Topics: Animals; Contrast Media; Edetic Acid; Magnetic Resonance Imaging; Manganese; Myocardial Infarction; Myocardium; Pyridoxal Phosphate; Rats | 2002 |
Platelet adhesiveness to glass.
Topics: Adult; Aged; Blood Gas Analysis; Bloodletting; Calcium; Citrates; Edetic Acid; Female; Glass; Heparin; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; Rotation; Silicones; Surgical Procedures, Operative; Temperature; Time Factors | 1979 |
Determination of phosphodiesterase I activity in human blood serum.
Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Edetic Acid; Female; Humans; Kinetics; Liver Cirrhosis; Lung Neoplasms; Male; Myocardial Infarction; Nitrophenols; Phosphates; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Thymine Nucleotides | 1975 |
Changes in glomerular filtration rate following myocardial infarction.
Topics: Adult; Aged; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Myocardial Infarction; Time Factors | 1975 |
Double-labeling of experimental acute myocardial infarcts with 113mIn- and 99mTc-EDTMP.
Topics: Animals; Disease Models, Animal; Dogs; Edetic Acid; Indium; Myocardial Infarction; Radioisotopes; Radionuclide Imaging; Technetium | 1976 |
Use of newer platelet function tests ot define abnormalities of hemostasis and thrombosis.
Topics: Acute Disease; Adult; Aged; Aspirin; Blood Cell Count; Blood Platelets; Edetic Acid; Hemostasis; Humans; Male; Myocardial Infarction; Platelet Aggregation; Thrombosis; Waldenstrom Macroglobulinemia | 1975 |
The effect of hypotonicity on the mean platelet volume of patients with thrombo-embolism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Platelets; Cell Membrane; Cell Size; Citrates; Citric Acid; Edetic Acid; Female; Humans; Hypotonic Solutions; Male; Microscopy, Electron, Scanning; Middle Aged; Myocardial Infarction; Osmotic Fragility; Postpartum Period; Pregnancy; Reproducibility of Results; Sodium Chloride; Thromboembolism | 1992 |
Optimized preservation of isoforms of creatine kinase MM isoenzyme in plasma specimens and their rapid quantification by semi-automated chromatofocusing.
Topics: Autoanalysis; Blood Preservation; Chromatography; Coronary Disease; Creatine Kinase; Edetic Acid; Humans; Isoelectric Focusing; Isoenzymes; Myocardial Infarction; Plasma; Specimen Handling | 1990 |
Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging.
Topics: Animals; Edetic Acid; Female; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1989 |
Differential hemodynamic effects of Hypaque-76 and Renografin-76 during coronary angiography: the role of calcium-binding additives.
Topics: Animals; Blood Pressure; Calcium; Citrates; Citric Acid; Contrast Media; Coronary Angiography; Diatrizoate; Diatrizoate Meglumine; Dogs; Drug Combinations; Edetic Acid; Electrocardiography; Heart; Hemodynamics; Myocardial Contraction; Myocardial Infarction | 1988 |
Measurement of creatine kinase MM sub-type by anion-exchange liquid chromatography.
Topics: Adenylate Kinase; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Creatine Kinase; Edetic Acid; Humans; Hydrogen-Ion Concentration; Isoelectric Focusing; Isoenzymes; Muscular Diseases; Myocardial Infarction; Osmolar Concentration; Reference Values; Temperature | 1985 |
About increase of aggregation of red cells with an increase of temperature in normal and abnormal blood (i.e. cancer). Effect of ABO blood groups and proteins.
Topics: ABO Blood-Group System; Anticoagulants; Blood Donors; Blood Group Antigens; Blood Proteins; Blood Sedimentation; Blood Viscosity; Cell Aggregation; Edetic Acid; Erythrocytes; Fibrinogen; Hematocrit; Hot Temperature; Humans; Myocardial Infarction; Neoplasms; Serum Albumin; Vascular Diseases | 1973 |
Myocardial lesions of calcium deficiency causing irreversible myocardial failure.
Topics: Animals; Calcium; Edetic Acid; Myocardial Infarction; Perfusion; Rabbits | 1966 |